Vyvanse 20 mg is a commonly prescribed medication for the treatment of attention deficit disorder with hyperactivity (ADHD) both in children and adults. It belongs to a class of medications known as stimulants of the central nervous system (CNS), which act affecting certain chemical substances of the brain that contribute to hyperactivity and impulse control.
Vyvanse 20 mg is indicated for the treatment of ADHD in patients from 6 years. It is not approved for weight loss or the treatment of obesity. Vyvanse should be used as part of a comprehensive treatment plan that includes psychological, educational and social measures, together with other no n-pharmacological interventions.
A remarkable feature of Vyvanse is the long duration of its effects. The active substance of Vyvanse is Lisdexanfetamine, which becomes dextroanfetamine after ingestion. This exclusive Profármaco formulation provides a prolonged release effect that can last up to 12 hours, allowing a daily dose and a constant therapeutic effect.
Key Features of Vyvanse 20 mg:
When Vyvanse prescribes, health professionals take into account various factors, such as age, weight and individual response to the medicine. It is available in different concentrations, being Vyvanse 20 mg the initial dose that is usually prescribed to people who start in treatment with ADHD stimulants.
| Dose | Color | Printed NDC number |
|---|---|---|
| 20 mg | Orange capsule | 0555-0768-01 |
| 30 mg | Blue capsule | 055-0769-01 |
| 40 mg | Blue capsule | 0555-0770-01 |
- Vyvanse is a controlled substance due to its potential for abuse and dependence. It must be stored safely and used only according to medical prescription.
- The dose of Vyvanse should be individualized according to the needs and response of the patient, under the supervision of a healthcare professional.
- The most common side effects of Vyvanse include decreased appetite, difficulty sleeping and irritability.
